Shanghai Model Organisms Center, Inc. (688265.SS)

CNY 24.61

(-2.3%)

Market Cap (In CNY)

1.98 Billion

Revenue (In CNY)

366.54 Million

Net Income (In CNY)

-20.58 Million

Avg. Volume

199.26 Thousand

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
19.42-38.64
PE
-
EPS
-
Beta Value
0.205
ISIN
CNE1000055L1
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Mingjun Wang
Employee Count
-
Website
https://www.modelorg.com
Ipo Date
2021-12-28
Details
Shanghai Model Organisms Center, Inc. engages in the research and development of genetically modified animal models in China. It develops tool, disease, fluorescent reporter, humanized, and immunodeficient mice; humanized, immunodeficient, disease, tool, and fluorescent reporter rats; and fluorescent-labeled, primary, and humanized cells. It also provides model customization, living body model, breeding, phenotypic analysis, and drug screening and evaluation services. The company was founded in 2000 and is headquartered in Shanghai, China.